Effect of coexisting cardiovascular disease on the long-term efficacy and safety of the implantable atrial defibrillator

PACE - Pacing and Clinical Electrophysiology

Volumn 25, Issue 5, 2002, Pages 809-815

  Tse, Hung Fat ^a   Lau, Chu Pak ^a   Rodriguez, Luz Maria ^b   Timmermans, Carl ^b   Daoud, Emile G ^a   Ayers, Gregory M ^c   Wellens, Hein J J ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c InControl/Guidant Inc ^*  (United States)

Author keywords

Atrial fibrillation; Implantable atrial defibrillator

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MALFORMATION; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; DEVICE; FEMALE; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; VALVULAR HEART DISEASE; EQUIPMENT; EVALUATION; FOLLOW UP; HEART DISEASE; MIDDLE AGED;

ADULT; AGED; ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT SAFETY; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMAN; HYPERTENSION; MALE; MIDDLE AGE; HUMANS; MIDDLE AGED;

EID: 0036090496     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2002.t01-1-00809.x     Document Type: Article

References (22)

1. Initial clinical experience with an implantable human atrial defibrillator
2. Atrioverter, an implantable device for the treatment of atrial fibrillation
3. Atrial fibrillation detection and R wave synchronization by Metrix implantable atrial defibrillator: Implication for long term efficacy and safety
4. Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: Observations on treated and nontreated episodes
5. Epidemiology and significance of atrial fibrillation
6. Clinical experience with a single pass dual electrode implantable atrial defibrillator lead for maintaining sinus rhythm in patients with recurrent atrial fibrillation
7. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV)
8. Assessment of cardiac function and myocardial contractility
9. The natural history of atrial fibrillation: Incidence, risk factors and prognosis in the Manitoba Follow-Up Study
10. Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study
11. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)
12. Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction
13. Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: A community-wide perspective
14. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials
15. Safety of transvenous low energy cardioversion of atrial fibrillation in patients with history of ventricular tachycardia: Effects of rate and repolarization time on proarrhythmic risk
16. Safety and efficacy of internal cardioversion of atrial fibrillation in patients with impaired left ventricular systolic function
17. Management of atrial arrhythmias secondary to severe congenital heart disease with the atrioverter
18. Cardioversion of atrial fibrillation in the setting of mild to moderate heart failure
19. Mechanoelectric feedback and atrial arrhythmias
20. Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort
21. Effects of experimental heart failure on atrial cellular and ionic electrophysiology
22. Basic mechanisms of atrial fibrillation - Very new insights into very old ideas